Company page

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. is a public company traded under the ticker DNA in the American market. With a market capitalization of approximately $599 million, Ginkgo focuses on leveraging its innovative platform for designing custom microbes for various applications. The company aims to advance biotechnology and synthetic biology solutions across multiple industries.